The first study included 897 women and reported TILs as an independent prognostic factor for a longer distant disease-free survival (HR: 0.76, 95% CI: 0.69–0.84, for every 10% increase in TILs) and longer OS (HR: 0.76, 95% CI: 0.68–0.84, for every 10% increase in TILs) in a model adjusted for age at diagnosis, lymph node stage, peritumoral vascular invasion, tumor size and grade, and Ki67 (54). Here, MKI67 is linked to neoplasm.